3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
14 Disclosed are 3,4,5-trisubstituted aryl nitrone compoundsd and pharmaceutical compositions containing such compounds. The 3,4,5-trisubstituted aryl nitrone compounds have formula (I); where R-Rare as defined in the specification. The disclosed compositions are useful as therapeutics for inflammat...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Waterbury, L. David Wilcox, Allan L Carney, John M Mavandadi, Farah Danielzadeh, Albert |
description | 14 Disclosed are 3,4,5-trisubstituted aryl nitrone compoundsd and pharmaceutical compositions containing such compounds. The 3,4,5-trisubstituted aryl nitrone compounds have formula (I); where R-Rare as defined in the specification. The disclosed compositions are useful as therapeutics for inflammation-related conditions in mammals, such as arthritis, and as analytical reagents for detecting free radicals. |
format | Patent |
fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_06998419</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>06998419</sourcerecordid><originalsourceid>FETCH-uspatents_grants_069984193</originalsourceid><addsrcrecordid>eNqNikEKwjAQAHvxIOof9gEtKK1izqL4AO9lTdZ2od2E7Obg71X0AZ6GYWZZ9W3d1fvGMmu5q7EVowCYnxMIW45C4OOcYpGggBIgjZhn9FSMPU7fqGwcRd8ihiwsA9hIoDjTulo8cFLa_Liq4HK-na5N0YRGYtoPGT_YHpw7djvX_rG8AEo7Pl0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same</title><source>USPTO Issued Patents</source><creator>Waterbury, L. David ; Wilcox, Allan L ; Carney, John M ; Mavandadi, Farah ; Danielzadeh, Albert</creator><creatorcontrib>Waterbury, L. David ; Wilcox, Allan L ; Carney, John M ; Mavandadi, Farah ; Danielzadeh, Albert ; Renovis, Inc</creatorcontrib><description>14 Disclosed are 3,4,5-trisubstituted aryl nitrone compoundsd and pharmaceutical compositions containing such compounds. The 3,4,5-trisubstituted aryl nitrone compounds have formula (I); where R-Rare as defined in the specification. The disclosed compositions are useful as therapeutics for inflammation-related conditions in mammals, such as arthritis, and as analytical reagents for detecting free radicals.</description><language>eng</language><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6998419$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64012</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6998419$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Waterbury, L. David</creatorcontrib><creatorcontrib>Wilcox, Allan L</creatorcontrib><creatorcontrib>Carney, John M</creatorcontrib><creatorcontrib>Mavandadi, Farah</creatorcontrib><creatorcontrib>Danielzadeh, Albert</creatorcontrib><creatorcontrib>Renovis, Inc</creatorcontrib><title>3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same</title><description>14 Disclosed are 3,4,5-trisubstituted aryl nitrone compoundsd and pharmaceutical compositions containing such compounds. The 3,4,5-trisubstituted aryl nitrone compounds have formula (I); where R-Rare as defined in the specification. The disclosed compositions are useful as therapeutics for inflammation-related conditions in mammals, such as arthritis, and as analytical reagents for detecting free radicals.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNikEKwjAQAHvxIOof9gEtKK1izqL4AO9lTdZ2od2E7Obg71X0AZ6GYWZZ9W3d1fvGMmu5q7EVowCYnxMIW45C4OOcYpGggBIgjZhn9FSMPU7fqGwcRd8ihiwsA9hIoDjTulo8cFLa_Liq4HK-na5N0YRGYtoPGT_YHpw7djvX_rG8AEo7Pl0</recordid><startdate>20060214</startdate><enddate>20060214</enddate><creator>Waterbury, L. David</creator><creator>Wilcox, Allan L</creator><creator>Carney, John M</creator><creator>Mavandadi, Farah</creator><creator>Danielzadeh, Albert</creator><scope>EFH</scope></search><sort><creationdate>20060214</creationdate><title>3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same</title><author>Waterbury, L. David ; Wilcox, Allan L ; Carney, John M ; Mavandadi, Farah ; Danielzadeh, Albert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_069984193</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Waterbury, L. David</creatorcontrib><creatorcontrib>Wilcox, Allan L</creatorcontrib><creatorcontrib>Carney, John M</creatorcontrib><creatorcontrib>Mavandadi, Farah</creatorcontrib><creatorcontrib>Danielzadeh, Albert</creatorcontrib><creatorcontrib>Renovis, Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Waterbury, L. David</au><au>Wilcox, Allan L</au><au>Carney, John M</au><au>Mavandadi, Farah</au><au>Danielzadeh, Albert</au><aucorp>Renovis, Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same</title><date>2006-02-14</date><risdate>2006</risdate><abstract>14 Disclosed are 3,4,5-trisubstituted aryl nitrone compoundsd and pharmaceutical compositions containing such compounds. The 3,4,5-trisubstituted aryl nitrone compounds have formula (I); where R-Rare as defined in the specification. The disclosed compositions are useful as therapeutics for inflammation-related conditions in mammals, such as arthritis, and as analytical reagents for detecting free radicals.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_uspatents_grants_06998419 |
source | USPTO Issued Patents |
title | 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T16%3A31%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Waterbury,%20L.%20David&rft.aucorp=Renovis,%20Inc&rft.date=2006-02-14&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E06998419%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |